AMLX - Amylyx Pharmaceuticals Inc Earnings

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: INDV ALKS KNSA LNTH TLX NBIX BMRN AXSM INCY VRTX

| Held by: VTI IWM VXF IWO IBB XPH VTWO SCHA IHE DFMC

Scroll to Statements

Index	RUT
Market Cap	2.22B
Enterprise Value	1.95B
Income	-150.11M
Sales	0.00M
Book/sh	2.46
Cash/sh	2.52
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	136
IPO	Jan 07, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	8.13
P/C	7.95
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	17.85
Current Ratio	17.85
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-1.51
EPS next Y	-1.34
EPS next Q	-0.36
EPS this Y	5.60%
EPS next Y	7.26%
EPS next 5Y	18.28%
EPS past 3/5Y	19.94% -15.37%
Sales past 3/5Y	- -
EPS Y/Y TTM	51.42%
Sales Y/Y TTM	-100.00%
EPS Q/Q	10.88%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-9.50% -

Insider Own	16.69%
Insider Trans	-0.79%
Inst Own	96.25%
Inst Trans	1.27%
ROA	-58.49%
ROE	-63.26%
ROIC	-54.07%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	10.12%
SMA50	24.12%
SMA200	35.38%
Trades

Shs Outstand	111.03M
Shs Float	92.63M
Short Float	13.24%
Short Ratio	8.21
Short Interest	12.27M
52W High	19.99 0.05%
52W Low	7.48 167.38%
Volatility	6.53% 6.33%
ATR (14)	1.12
RSI (14)	66.65
Beta	-0.20
Rel Volume	0.62
Avg Volume	1.49M
Volume	717,371

Perf Week	12.99%
Perf Month	6.95%
Perf Quarter	22.62%
Perf Half Y	29.28%
Perf YTD	65.56%
Perf Year	151.57%
Perf 3Y	-11.27%
Perf 5Y	-
Perf 10Y	-
Recom	1.10
Target Price	24.89
Prev Close	19.55
Price	20.00
Change	2.30%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)